Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Related Articles by Review for PubMed (Select 20001453)

1.

Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation.

Kim C, Majdi M, Xia P, Wei KA, Talantova M, Spiering S, Nelson B, Mercola M, Chen HS.

Stem Cells Dev. 2010 Jun;19(6):783-95. doi: 10.1089/scd.2009.0349.

2.

Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.

Blazeski A, Zhu R, Hunter DW, Weinberg SH, Boheler KR, Zambidis ET, Tung L.

Prog Biophys Mol Biol. 2012 Oct-Nov;110(2-3):178-95. doi: 10.1016/j.pbiomolbio.2012.07.012. Epub 2012 Aug 7. Review.

3.

Calcium handling in embryonic stem cell-derived cardiac myocytes: of mice and men.

Itzhaki I, Schiller J, Beyar R, Satin J, Gepstein L.

Ann N Y Acad Sci. 2006 Oct;1080:207-15. Review.

PMID:
17132785
4.

Calcium signalling of human pluripotent stem cell-derived cardiomyocytes.

Li S, Chen G, Li RA.

J Physiol. 2013 Nov 1;591(Pt 21):5279-90. doi: 10.1113/jphysiol.2013.256495. Epub 2013 Sep 9. Review.

5.

Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.

van den Heuvel NH, van Veen TA, Lim B, Jonsson MK.

J Mol Cell Cardiol. 2014 Feb;67:12-25. doi: 10.1016/j.yjmcc.2013.12.011. Epub 2013 Dec 23. Review.

PMID:
24370890
6.

Human embryonic stem cell-derived cardiomyocytes for heart therapies.

Siu CW, Moore JC, Li RA.

Cardiovasc Hematol Disord Drug Targets. 2007 Jun;7(2):145-52. Review.

PMID:
17584049
7.

Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.

Yang HT, Zhang M, Huang J, Liang H, Zhang P, Boheler KR.

Exp Cell Res. 2013 Jan 15;319(2):120-5. doi: 10.1016/j.yexcr.2012.09.011. Epub 2012 Sep 25. Review.

PMID:
23022397
8.

Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective.

Poon E, Kong CW, Li RA.

Mol Pharm. 2011 Oct 3;8(5):1495-504. doi: 10.1021/mp2002363. Epub 2011 Sep 8. Review.

9.

Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.

de Jong E, Doedée AM, Reis-Fernandes MA, Nau H, Piersma AH.

Reprod Toxicol. 2011 May;31(4):375-82. doi: 10.1016/j.reprotox.2010.11.012. Epub 2010 Nov 27. Review.

PMID:
21115111
10.

Trophoblast differentiation of human embryonic stem cells.

Tiruthani K, Sarkar P, Rao B.

Biotechnol J. 2013 Apr;8(4):421-33. doi: 10.1002/biot.201200203. Epub 2013 Jan 17. Review.

PMID:
23325630
11.

Developmental regulation of intracellular calcium homeostasis in early cardiac myocytes.

Fu JD, Yang HT.

Sheng Li Xue Bao. 2006 Apr 25;58(2):95-103. Review.

12.

Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes.

Robertson C, Tran DD, George SC.

Stem Cells. 2013 May;31(5):829-37. doi: 10.1002/stem.1331. Review.

13.

Human embryonic stem cell-derived cardiomyocytes: inducing strategies.

Gallo P, Condorelli G.

Regen Med. 2006 Mar;1(2):183-94. Review.

PMID:
17465802
14.

Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.

Mandenius CF, Steel D, Noor F, Meyer T, Heinzle E, Asp J, Arain S, Kraushaar U, Bremer S, Class R, Sartipy P.

J Appl Toxicol. 2011 Apr;31(3):191-205. doi: 10.1002/jat.1663. Epub 2011 Feb 16. Review.

PMID:
21328588
15.

Cardiac differentiation of human pluripotent stem cells.

Jiang J, Han P, Zhang Q, Zhao J, Ma Y.

J Cell Mol Med. 2012 Aug;16(8):1663-8. doi: 10.1111/j.1582-4934.2012.01528.x. Review.

16.

Cardiomyocytes from human embryonic stem cells.

Passier R, Denning C, Mummery C.

Handb Exp Pharmacol. 2006;(174):101-22. Review.

PMID:
16370326
17.

Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.

Dick E, Rajamohan D, Ronksley J, Denning C.

Biochem Soc Trans. 2010 Aug;38(4):1037-45. doi: 10.1042/BST0381037. Review.

PMID:
20659000
18.

The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.

van Dartel DA, Piersma AH.

Reprod Toxicol. 2011 Sep;32(2):235-44. doi: 10.1016/j.reprotox.2011.04.008. Epub 2011 May 6. Review.

PMID:
21575713
19.

Review: Trophoblast differentiation from human embryonic stem cells.

Golos TG, Giakoumopoulos M, Gerami-Naini B.

Placenta. 2013 Mar;34 Suppl:S56-61. doi: 10.1016/j.placenta.2012.11.019. Epub 2012 Dec 20. Review.

20.

Molecular and phenotypic analyses of human embryonic stem cell-derived cardiomyocytes: opportunities and challenges for clinical translation.

Goh G, Self T, Barbadillo Muñoz MD, Hall IP, Young L, Denning C.

Thromb Haemost. 2005 Oct;94(4):728-37. Review.

PMID:
16270624
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk